Results 11 to 20 of about 3,591 (202)

Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles

The Oncologist, 2022
Background The relationship between CINV duration and recurrence in subsequent cycles is largely unstudied. Our objective was to determine if patients experiencing CINV in their first cycle of chemotherapy (C1) would face increased risk
Kloth, Dwight D., Herrstedt, Jørn, Gary Binder, Schwartzberg, Lee, Molasiotis, Alex, Kathryn J Ruddy, Dwight D Kloth, Binder, Gary, Jørn Herrstedt, Eros Papademetriou, Roeland, Eric J., Kelsey A Klute, Ruddy, Kathryn J., Rudolph Navari, Eric J Roeland, Schmerold, Luke, Alex Molasiotis, Thomas W LeBlanc, Papademetriou, Eros, LeBlanc, Thomas W., Klute, Kelsey A., Luke Schmerold, Lee Schwartzberg, Navari, Rudolph   +23 more
core   +4 more sources

Chemotherapy-Induced Nausea and Vomiting (CINV) with GI Cancer Chemotherapy: Do We Need CINV Risk Score Over and Above Antiemetic Guidelines in Prescribing Antiemetic Regime?

South Asian Journal of Cancer, 2020
Background Various predictive models have been developed which incorporates patient risk factors into the selection of optimal antiemetic therapy, one of which is chemotherapy-induced nausea and vomiting (CINV) risk scoring system developed by ...
Anita D’Souza, Dipalee Pawar, Anant Ramaswamy, Siddharth Turkar, Prabhat Bhargava, Akhil Kapoor, Sarika Mandavkar, Chaitali Nashikkar, Vikas Ostwal   +8 more
doaj   +2 more sources

Prospective observational study on chemotherapy-induced nausea and vomiting (CINV) for colorectal cancer patients by the CINV study group of Japan.

Journal of Clinical Oncology, 2014
652 Background: The aim of this study is to investigate the incidence of Chemotherapy Induced Nausea and Vomiting (CINV) among moderately emetogenic chemotherapy-naive patients with colorectal cancer.
Koji Takeda, Michiya Kobayashi, Hideo Baba, Kazuhiro Yoshida, Yoshihiro Kakeji, Yoshihiko Maehara, Ayako Doi, Yuji Miyamoto, Masahiro Gotoh, Norihiro Kokudo, Yasushi Tsuji, Keisuke Aiba   +11 more
core   +2 more sources

Chemotherapy-Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline-Free Regimen With Docetaxel, Cyclophosphamide-Results From a Randomized Clinical Trial. [PDF]

Int J Cancer
Chemotherapy‐induced nausea and vomiting (CINV) remains a significant clinical problem despite modern antiemetics. In particular, antiemetic strategies for emerging cancer therapies lack detailed evaluation. This randomized trial analyzed hourly CINV data for patients with early breast cancer who received either docetaxel plus cyclophosphamide (TC) or ...
Hörner M, Schäffler H, Häberle L, Goossens C, Pfister K, Leinert E, Veselinovic K, Brucker SY, Köhler U, Heinrich G, Schneeweiss A, Beckmann MW, Fasching PA, Janni W, Rack B, Heublein S, Ziegler P.   +16 more
europepmc   +2 more sources

Current Management of CINV

European Journal of Medical and Health Sciences, 2023
Chemotherapy-induced nausea and vomiting (CINV) prevention is important to reduce overall morbidity and financial burden in patients receiving chemotherapy. Severe symptoms reduce the patient's quality of life and can interfere with further treatment.
I Nyoman Bayu Mahendra, William Alexander Setiawan   +1 more
openaire   +1 more source

Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends

Cancer Treatment and Research Communications, 2021
The significant physical and emotional effects of chemotherapy-induced nausea and vomiting (CINV) are experienced by cancer patients. Severe symptoms decrease the patient's quality of life and potentially deters further treatment.
Kush Gupta, Rebecca Walton, S.P. Kataria
doaj   +1 more source

Incidence and Risk Factors of Delayed Chemotherapy-Induced Nausea and Vomiting Among Adult Patients: A Cross-Sectional Study. [PDF]

Nurs Open
ABSTRACT Aim To assess the incidence of delayed chemotherapy‐induced nausea and vomiting (CINV) and identify key risk factors among adult patients. Design A descriptive cross‐sectional design. Methods A total of 326 adult patients undergoing chemotherapy were recruited using consecutive sampling from a nearly 4000‐bed tertiary general hospital in ...
Zheng M, Zhang Q, Ni L, Zheng Z, Wang Y, Chen Y, Huang J, Gao J, Li Q, Zhang Y.   +9 more
europepmc   +2 more sources

Transient Receptor Potential Vanilloid 1 Function at Central Synapses in Health and Disease

Frontiers in Cellular Neuroscience, 2022
The transient receptor potential vanilloid 1 (TRPV1), a ligand-gated nonselective cation channel, is well known for mediating heat and pain sensation in the periphery. Increasing evidence suggests that TRPV1 is also expressed at various central synapses,
Rodrigo C. Meza, Carlos Ancatén-González, Carlos Ancatén-González, Chiayu Q. Chiu, Andrés E. Chávez   +4 more
doaj   +1 more source

Chemotherapy-Induced Nausea and Vomiting in Gastrointestinal Cancer Patients: Do We Need to Revisit Guidelines?

South Asian Journal of Cancer, 2020
Purpose The objective of this study was to assess the proportion of patients developing chemotherapy-induced nausea and vomiting (CINV) after receiving chemotherapy for gastrointestinal (GI) cancers, despite receiving antiemetic prophylaxis (AEP) as per ...
Akhil Kapoor, Ashutosh Jain, Abhishek Sharma, Minit Shah, Shravan Chinthala, Ravindra Nandhana, Prabhat Bhargava, Anant Ramaswamy, Sujay Srinivas, Vikas Ostwal   +9 more
doaj   +1 more source

Quantification of Bacteria Residing in Caenorhabditis elegans Intestine

Bio-Protocol, 2020
Quantification of intestinal colonization by pathogenic or commensal bacteria constitute a critical part of the analysis to understand host-microbe interactions during different time points of their interplay.
M. Fernanda Palominos, Andrea Calixto
doaj   +1 more source